Showing posts with label
Ai drug creation
.
Show all posts
Showing posts with label
Ai drug creation
.
Show all posts
Tuesday, November 19, 2024
last weeks merger of Recursion (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) can be a game changer!
›
The Transformative Impact of AI and Genomics on Healthcare and Medicine and the impact of last weeks merger of Recursion (RXRX) and Exsc...
›
Home
View web version
